Cipla receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cipla Ltd. (CIPL)
Cipla Ltd. stock price live, this page displays NSE CIPL stock exchange data. View the CIPL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cipla Ltd. real time stock price chart below.
What Is the Cipla Ltd. Stock Price Today?
The Cipla Ltd. stock price today is 1,397.70.
What Is the Stock Symbol for Cipla Ltd.?
The stock symbol for Cipla Ltd. is "CIPL."
What Stock Exchange Does Cipla Ltd. Trade On?
Cipla Ltd. is listed and trades on the NSE stock exchange.
Is Cipla Ltd. a Good Stock to Buy?
Determining whether Cipla Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CIPL quote. (ISIN: INE059A01026)
What Is the Cipla Ltd. Stock Price Today?
The Cipla Ltd. stock price today is 1,397.70.
What Is the Stock Symbol for Cipla Ltd.?
The stock symbol for Cipla Ltd. is "CIPL."
What Stock Exchange Does Cipla Ltd. Trade On?
Cipla Ltd. is listed and trades on the NSE stock exchange.
Is Cipla Ltd. a Good Stock to Buy?
Determining whether Cipla Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CIPL quote. (ISIN: INE059A01026)
1,397.70
-4.30(-0.31%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,390.20
1,408.00
52 wk Range
1,165.70
1,539.70
CIPLA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,390.201,408.00
52 wk Range
1,165.701,539.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CIPLA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
1,507.31
Upside
+7.84%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Cipla receives Investment Bank Analyst Rating Update- Investing.com
Pro
Cipla receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Cipla receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cipla receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
- Cipla receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
22 Buy
12 Hold
2 Sell
Ratings:
36 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 1,507.31
(+7.84% Upside)
Cipla Ltd. Earnings Call Summary for Q2/2027
- Cipla Q2 FY2027 revenue rose 4% QoQ to INR 7,404 crores; EBITDA margin expanded 200bps to 18.7% on improved product mix and execution.
- India business posted 12% YoY growth with branded prescriptions up 15%; company maintained No. 1 U.S. albuterol MDI position at 22% market share.
- Management reaffirmed FY2027 EBITDA margin guidance of 18.5%-20% and $1B annualized North America revenue run rate target by year-end.
- Shares fell 1.85% to $1,330 as investors weighed FDA approval timing risks and dependence on limited respiratory product launches for U.S. growth.
- Company targets pembrolizumab biosimilar filing in 2028 for 2029 launch; Pithampur facility received 7 FDA observations requiring remediation.
Last Updated: 10/27/2026, 07:44 PM
Read Full TranscriptEarnings
Latest Release
Oct 26, 2026
EPS / Forecast
10.85 / 11.54
Revenue / Forecast
74.04B / 76.23B
Compare CIPLA to Peers and Sector
Metrics to compare | CIPLA | Peers Peers - average of corresponding metrics from companies closely matching CIPLA: ZYDUSLIFE, SUNPHARMA, ALKEM, AJANTPHARM, AUROPHARMA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCIPLAPeersSector |
|---|---|---|---|---|
P/E Ratio | 39.1x | 30.2x | −0.2x | |
PEG Ratio | −0.84 | 0.52 | 0.00 | |
Price/Book | 3.2x | 4.2x | 2.6x | |
Price / LTM Sales | 4.0x | 4.0x | 2.8x | |
Upside (Analyst Target) | 7.7% | 14.1% | 62.7% | |
Fair Value Upside | Unlock | −0.5% | 8.0% | Unlock |
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Cipla (CIPLA) Stock Price Today?
The Cipla stock price today is 1,397.70 INR.
What Stock Exchange Does Cipla Trade On?
Cipla is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Cipla?
The stock symbol for Cipla is "CIPLA."
Does Cipla Pay Dividends? What’s The Current Dividend Yield?
The Cipla dividend yield is 0.9%%.
What Is the Cipla Market Cap?
As of today, Cipla market cap is 1.13T INR.
What Is Cipla's Earnings Per Share (TTM)?
The Cipla EPS (TTM) is 35.86.
When Is the Next Cipla Earnings Date?
Cipla will release its next earnings report on Jan 22, 2027.
From a Technical Analysis Perspective, Is CIPLA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Cipla Stock Split?
Cipla has split 3 times.
How Many Employees Does Cipla Have?
Cipla has 31369 employees.
What is the current trading status of Cipla (CIPLA)?
As of Nov 05, 2026, Cipla (CIPLA) is trading at a price of 1,397.70 INR, with a previous close of 1,402.00 INR. The stock has fluctuated within a day range of 1,390.20 INR to 1,408.00 INR, while its 52-week range spans from 1,165.70 INR to 1,539.70 INR.
What Is Cipla (CIPLA) Price Target According to Analysts?
The average 12-month price target for Cipla is 1,507.31 INR, with a high estimate of 1800 INR and a low estimate of 1214 INR. 22 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an +7.84% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.